NCT03046758View on ClinicalTrials.gov

The Safety and Pharmacokinetics of Intraperitoneal Administration in Patients Undergoing Appendectomy for Uncomplicated Appendicitis

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 24, 2017

Primary Completion Date

December 7, 2017

Study Completion Date

December 7, 2017

Conditions

Appendicitis

Interventions

DRUG

A combination of fosfomycin, metronidazole and GM-CSF i.p.

All drugs will be administered together intraperitoneally at the end of the surgery after the appendix has been removed.

Trial Locations (1)

2730

Department of Surgery, Herlev Hospital, Herlev

All Listed Sponsors

collaborator

Jacob Rosenberg (Sponsor)

UNKNOWN

collaborator

Barbara Juliane Holzknecht (Investigator)

UNKNOWN

collaborator

Magnus Arpi (Investigator)

UNKNOWN

collaborator

Johan Juhl Weisser (Partner, data analysis)

UNKNOWN

lead

Herlev Hospital

OTHER

NCT03046758 - The Safety and Pharmacokinetics of Intraperitoneal Administration in Patients Undergoing Appendectomy for Uncomplicated Appendicitis | Biotech Hunter | Biotech Hunter